User profiles for "author:Laith J Abu-Raddad"

Laith J. Abu-Raddad

Professor of Healthcare Policy and Research, Weill Cornell Medical College – Qatar
Verified email at qatar-med.cornell.edu
Cited by 122669

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a …

T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov… - The lancet, 2015 - thelancet.com
Background Up-to-date evidence about levels and trends in disease and injury incidence,
prevalence, and years lived with disability (YLDs) is an essential input into global, regional …

[HTML][HTML] Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

DR Feikin, MM Higdon, LJ Abu-Raddad, N Andrews… - The lancet, 2022 - thelancet.com
Background Knowing whether COVID-19 vaccine effectiveness wanes is crucial for
informing vaccine policy, such as the need for and timing of booster doses. We aimed to …

Vertical transmission of hepatitis C virus: systematic review and meta-analysis

L Benova, YA Mohamoud, C Calvert… - Clinical infectious …, 2014 - academic.oup.com
Vertical Transmission of Hepatitis C Virus: Systematic Review and Meta-analysis | Clinical
Infectious Diseases | Oxford Academic Skip to Main Content Advertisement Oxford Academic …

[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the …

T Vos, C Allen, M Arora, RM Barber, ZA Bhutta… - The lancet, 2016 - thelancet.com
Background Non-fatal outcomes of disease and injury increasingly detract from the ability of
the world's population to live in full health, a trend largely attributable to an epidemiological …

[HTML][HTML] Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic …

T Vos, AA Abajobir, KH Abate, C Abbafati, KM Abbas… - The Lancet, 2017 - thelancet.com
Background As mortality rates decline, life expectancy increases, and populations age, non-
fatal outcomes of diseases and injuries are becoming a larger component of the global …

[HTML][HTML] Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990 …

MH Forouzanfar, A Afshin, LT Alexander, HR Anderson… - The lancet, 2016 - thelancet.com
Summary Background The Global Burden of Diseases, Injuries, and Risk Factors Study
2015 provides an up-to-date synthesis of the evidence for risk factor exposure and the …

[HTML][HTML] Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for …

H Wang, M Naghavi, C Allen, RM Barber, ZA Bhutta… - The lancet, 2016 - thelancet.com
Background Improving survival and extending the longevity of life for all populations
requires timely, robust evidence on local mortality levels and trends. The Global Burden of …

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013 …

CJL Murray, RM Barber, KJ Foreman, AA Ozgoren… - The Lancet, 2015 - thelancet.com
Summary Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring
together all available epidemiological data using a coherent measurement framework …

[HTML][HTML] Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar

H Chemaitelly, P Tang, MR Hasan… - … England Journal of …, 2021 - Mass Medical Soc
Background Waning of vaccine protection against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection or coronavirus disease 2019 (Covid-19) is a concern …

[HTML][HTML] Effectiveness of the BNT162b2 Covid-19 Vaccine against the B. 1.1. 7 and B. 1.351 Variants

LJ Abu-Raddad, H Chemaitelly… - New England Journal of …, 2021 - Mass Medical Soc
Efficacy of the BNT162b2 mRNA Vaccine in Qatar As of March 31, 2021, more than 265,000
people in Qatar had received both doses of the BNT162b2 vaccine. Viral sequencing …